ABL-class Genomic Breakpoint Q-PCR: A Patient-specific Approach for MRD Monitoring in Acute Lymphoblastic Leukemia.

Autor: van Outersterp I; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van der Velden VHJ; Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Center Rotterdam, The Netherlands., Hoogeveen PG; Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Center Rotterdam, The Netherlands., Vaitkevičienė GE; Faculty of Medicine, Vilnius University, Lithuania.; Center for Pediatric Oncology and Hematology, Vilnius University Hospital Santaros Klinikos, Lithuania., Sonneveld E; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Dutch Childhood Oncology Group, Utrecht, The Netherlands., van Haaften G; Department of Genetics, University Medical Center Utrecht, The Netherlands., Kuiper RP; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Genetics, University Medical Center Utrecht, The Netherlands., Zur Stadt U; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Germany., Escherich G; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Germany., Boer JM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., den Boer ML; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology and Hematology, Erasmus MC - Sophia Children's Hospital, Rotterdam, The Netherlands.
Jazyk: angličtina
Zdroj: HemaSphere [Hemasphere] 2023 Sep 19; Vol. 7 (10), pp. e967. Date of Electronic Publication: 2023 Sep 19 (Print Publication: 2023).
DOI: 10.1097/HS9.0000000000000967
Abstrakt: Competing Interests: The authors have no conflicts of interest to disclose.
Databáze: MEDLINE